Periscope Capital’s AfterNext HealthTech Acquisition Corp Warrants AFTR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-646,521
Closed -$56K 687
2023
Q2
$56K Sell
646,521
-11,965
-2% -$2.34K ﹤0.01% 419
2023
Q1
$110K Buy
658,486
+8,832
+1% +$1.36K 0.01% 429
2022
Q4
$48.7K Buy
649,654
+485,498
+296% +$48.5K ﹤0.01% 580
2022
Q3
$26K Buy
164,156
+64,356
+64% +$15.1K ﹤0.01% 820
2022
Q2
$19K Hold
99,800
﹤0.01% 963
2022
Q1
$42K Buy
+99,800
New +$54.2K ﹤0.01% 995

Periscope Capital's AFTR.WS Position: Q3 2023 in Review

Periscope Capital sold out of AfterNext HealthTech Acquisition Corp Warrants (AFTR.WS) in Q3 2023, closing a stake of 646,521 shares — an estimated $56K sold.

Periscope Capital first reported a position in AFTR.WS in Q1 2022 and held it in 6 quarters. The position peaked at $110K in Q1 2023. 0 funds tracked by Wall St. Rank hold AFTR.WS as of Q3 2023.

  • Periscope Capital reported no remaining AfterNext HealthTech Acquisition Corp Warrants position as of Q3 2023 after selling out during the quarter.
  • Periscope Capital sold 646,521 AfterNext HealthTech Acquisition Corp Warrants shares in Q3 2023, an estimated $56K.
  • Periscope Capital first reported a position in AfterNext HealthTech Acquisition Corp Warrants in Q1 2022 and held it in 6 quarters.
  • Periscope Capital's AfterNext HealthTech Acquisition Corp Warrants position peaked at $110K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp Warrants as of Q3 2023.

Based on Periscope Capital's 13F filing for Q3 2023, filed 6 Nov 2023.